These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9513799)

  • 41. Reinforcing and subjective effects of the volatile anesthetic, sevoflurane.
    Walker DJ; Beckman NJ; Zacny JP
    Drug Alcohol Depend; 2004 Nov; 76(2):191-201. PubMed ID: 15488343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Acute pancreatitis after intravenous buprenorphine misuse in a heroin addict].
    Sepulveda S; Dermine H; Mulot A; Villard M; Haberer JP
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):658-9. PubMed ID: 15234740
    [No Abstract]   [Full Text] [Related]  

  • 44. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abuse liability assessment of atomoxetine in a drug-abusing population.
    Jasinski DR; Faries DE; Moore RJ; Schuh LM; Allen AJ
    Drug Alcohol Depend; 2008 May; 95(1-2):140-6. PubMed ID: 18328639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous buprenorphine self-administration by detoxified heroin abusers.
    Comer SD; Collins ED; Fischman MW
    J Pharmacol Exp Ther; 2002 Apr; 301(1):266-76. PubMed ID: 11907183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An existential theory of drug dependence.
    Greaves GB
    NIDA Res Monogr; 1980 Mar; 30():24-8. PubMed ID: 6779185
    [No Abstract]   [Full Text] [Related]  

  • 51. The clinical pharmacology of pentazocine and tripelennamine (T's and Blues).
    Lange WR; Jasinski DR
    Adv Alcohol Subst Abuse; 1986; 5(4):71-83. PubMed ID: 3751735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A general theory of addiction to opiate-type drugs.
    Lindesmith AR
    NIDA Res Monogr; 1980 Mar; 30():34-7. PubMed ID: 6779192
    [No Abstract]   [Full Text] [Related]  

  • 53. Abuse-liability and narcotic antagonism of pentazocine (report of two cases).
    Keup W
    Dis Nerv Syst; 1968 Sep; 29(9):599-602. PubMed ID: 5717275
    [No Abstract]   [Full Text] [Related]  

  • 54. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men.
    Ciraulo DA; Barnhill JG; Greenblatt DJ; Shader RI; Ciraulo AM; Tarmey MF; Molloy MA; Foti ME
    J Clin Psychiatry; 1988 Sep; 49(9):333-7. PubMed ID: 3417618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Buprenorphine versus heroin dependence: comparison of toxicologic and psychopathologic characteristics.
    Torrens M; San L; Camí J
    Am J Psychiatry; 1993 May; 150(5):822-4. PubMed ID: 8480833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man.
    Mendelson JH; Teoh SK; Mello NK; Ellingboe J
    Neuropsychopharmacology; 1992 Sep; 7(2):157-62. PubMed ID: 1329800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toward a theory of drug subcultures.
    Johnson BD
    NIDA Res Monogr; 1980 Mar; 30():110-9. PubMed ID: 6779165
    [No Abstract]   [Full Text] [Related]  

  • 58. [Buprenorphine abuse in a series of 50 drug addicts hospitalized at a Drug Dependence Evaluation hospital in Marseille].
    Arditti J; Bourdon JH; Jean P; Landi H; Nasset D; Jouglard J; Thirion X
    Therapie; 1992 Nov; 47(6):561-2. PubMed ID: 1301649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Narcotic-related deaths in the District of Columbia: 1971-1979.
    Zimney EL; Luke JL
    J Forensic Sci; 1981 Jul; 26(3):462-9. PubMed ID: 7252460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of the abuse liability of buspirone in alcohol-dependent patients.
    Griffith JD; Jasinski DR; Casten GP; McKinney GR
    Am J Med; 1986 Mar; 80(3B):30-5. PubMed ID: 3963032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.